PATENT ASSIGNEE'S COUNTRY | USA |
UPDATE | 01.00 |
PATENT ASSIGNEE | Vertex Pharma |
PATENT CLAIMS | Oral adm of crosslinked enzyme crystal having resistance to exogenous proteolysis, such that said crosslinked enzyme retains > 91% of its initial activity after incubation for 3 hours in presence of a concn of Pronase that causes soluble uncrosslinked form to lose > 94% of its initial activity under same conditions |
PATENT PHOTOCOPY | Available on request |
Want more information ? Interested in the hidden information ? Click here and do your request. |